Phase II Double Blind Randomized Trial Evaluating the Biologic Effect of Levonorgestrel on the Ovarian Epithelium in Women at High Risk for Ovarian Cancer (IND# 79,610)
Principal Investigator
,
Status
Terminated
Date of Study Termination
April 10 2020
Disease Site
Gynecologic [GY]
Ovarian
Phase
II
Developmental Therapeutics
No
Primary Objective
To determine the impact of levonorgestrel on the relative frequency of apoptosis in the ovarian epithelium from women with a high risk of ovarian cancer.
Patient Population
Target Accrual
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.